FDA Approves First Chinese Cancer Drug for U.S. Patient Use

(Bloomberg) -- The U.S. Food and Drug Administration has granted approval to a blood cancer drug from Beijing-based BeiGene Ltd., paving the way for American patients to access a Chinese cancer the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.